Hospital Acquired Disease Testing Market Report

Hospital Acquired Disease Testing Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: GVR915

The increasing morbidity rates of Nosocomial infection worldwide along with the prevalence of pathogens, bacterial, fungal & viral diseases are the vital drivers for the growth of hospital acquired infection or hospital associated infection (HAI) diagnostics market. Another important driving force is increasing length of stay in the hospital which is primarily due to hospital acquired infections. HAI is more likely to occur in the intensive care units (ICU) & the emergency rooms (ER). CDC, U.S. estimates that, 5 % patients admitted in a hospital get HAI of any form within 72 hours of their stay. Infections incubating but clinically not visible at the time of admission are excluded. The most frequent type of infection that spreads in the hospital settings are bacterial nosocomial infections. These infections are commonly transmitted when hospital staff do not practice proper hygiene correctly & become complacent. 

Globally, the Nosocomial infection market is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections such as cardio vascular infection, gastrointestinal infections & respiratory infections. Of all the different types of HAI, urinary tract infection is the most common one & has the largest share in overall HAI testing market. The popular techniques that are being used for preventing, diagnosing & treating the hospital associated infections are: PCR, solid phase hybridization, microarrays. There are different government bodies which provide defined guidelines for control & prevention of HAI in developing countries. National health & medical research council, Australia & CDC, U.S. have provided a framework of recommendations to healthcare organizations to manage the different types of HAI. 

North America has the largest share in this market followed by Europe. Due to the increase in medical tourism industry in Asian countries, the Asia-Pacific market is expected to flourish in the forecasted period. The key players in this market include - Life technologies, Diatherix laboratories, Qiagen GmbH, Meridian Biosciences, Nordion, Roche, Cantel Medical Corporation, Cepheid & others.

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA